Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lennert Steukers

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Infectious Diseases|January 18, 2014
Mimicking herpes simplex virus 1 and herpes simplex virus 2 mucosal behavior in a well-characterized human genital organ cultureLennert Steukers, Steven Weyers, Xiaoyun Yang, et al.
Antiviral Research|December 20, 2011
Evaluation of the antiviral activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explantsSarah Glorieux, Annelies P Vandekerckhove, Nesya Goris, et al.
Plos One|July 27, 2011
Herpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosaSarah Glorieux, Claus Bachert, Herman W Favoreel, et al.
The Journal of General Virology|May 19, 2017
Us3 and Us9 proteins contribute to the stromal invasion of bovine herpesvirus 1 in the respiratory mucosaJing Zhao, Katrien C K Poelaert, Lennert Steukers, et al.
Frontiers in Neurology|August 7, 2023
Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership modelAngela Bradshaw, Nigel Hughes, David Vallez-Garcia, et al.
Ebiomedicine|September 19, 2025
Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled studyOlivier Sol, Julien Mermoud, Merja Hallikainen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Infectious Diseases|January 18, 2014
Mimicking herpes simplex virus 1 and herpes simplex virus 2 mucosal behavior in a well-characterized human genital organ cultureLennert Steukers, Steven Weyers, Xiaoyun Yang, et al.
Antiviral Research|December 20, 2011
Evaluation of the antiviral activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explantsSarah Glorieux, Annelies P Vandekerckhove, Nesya Goris, et al.
Plos One|July 27, 2011
Herpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosaSarah Glorieux, Claus Bachert, Herman W Favoreel, et al.
The Journal of General Virology|May 19, 2017
Us3 and Us9 proteins contribute to the stromal invasion of bovine herpesvirus 1 in the respiratory mucosaJing Zhao, Katrien C K Poelaert, Lennert Steukers, et al.
Frontiers in Neurology|August 7, 2023
Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership modelAngela Bradshaw, Nigel Hughes, David Vallez-Garcia, et al.
Ebiomedicine|September 19, 2025
Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled studyOlivier Sol, Julien Mermoud, Merja Hallikainen, et al.
Pageof 2